0001585608-18-000009.txt : 20180927 0001585608-18-000009.hdr.sgml : 20180927 20180926214012 ACCESSION NUMBER: 0001585608-18-000009 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180926 EFFECTIVENESS DATE: 20180927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-322250 FILM NUMBER: 181089326 BUSINESS ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-896-5081 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 D 1 primary_doc.xml X0708 D LIVE 0001585608 Jaguar Health, Inc. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA CALIFORNIA 94105 415-896-5081 DELAWARE Jaguar Animal Health, Inc. Corporation true Lisa Conte 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Executive Officer Director Promoter James J. Bochnowski 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director Jiahao Qui 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director Greg J. Divis 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director Karen S. Wright 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Executive Officer Steven R. King 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Executive Officer Murray David MacNaughtan 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director Jonathan B Siegel 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director John Micek, III 201 MISSION STREET, SUITE 2375 San Francisco CA CALIFORNIA 94105 Director Jeffrey C Johnson 280 Park Avenue, 3rd Floor West New York NY NEW YORK 10017 Director Pharmaceuticals Decline to Disclose 06b false 2018-09-11 false true true true true Convertible Promissory Note and Common Stock Warrants and the underlying common stock issuable upon conversion and exercise thereof. false 0 774844 774844 0 false 2 0 0 0 false Jaguar Health, Inc. /s/ Karen S. Wright Karen S. Wright Chief Financial Officer 2018-09-19